Search Results - "Lus G"

A snapshot on patient-reported outcome measures of people with multiple sclerosis on first-line therapies in a real world setting.

Authors: Lanzillo, R. Sparaco, M. Lavorgna, L. et al.

Source: Neurological Sciences. Nov2020, Vol. 41 Issue 11, p3235-3241. 7p. 5 Charts.

Subjects: Multiple sclerosis, Glatiramer acetate, Drug side effects, Interferons, Health surveys

Fingolimod efficacy in multiple sclerosis associated with Sjogren syndrome.

Authors: Signoriello, E. Sagliocchi, A. Fratta, M. et al.

Source: Acta Neurologica Scandinavica. Feb2015, Vol. 131 Issue 2, p140-143. 4p.

Subjects: Fingolimod, Drug efficacy, Multiple sclerosis, Sjogren's syndrome, Disease relapse, Demyelination

Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases.

Authors: Ghezzi, A. Annovazzi, P. Cocco, E. et al.

Source: Neurological Sciences. Sep2013, Vol. 34 Issue 9, p1633-1637. 5p.

Subjects: Endovascular surgery, Venous insufficiency, Multiple sclerosis, Health outcome assessment, Italians, Retrospective studies, Questionnaires, Therapeutics, Diseases

Fluctuations of MS births and UV-light exposure.

Authors: Verheul, F. Smolders, J. Trojano, M. et al.

Source: Acta Neurologica Scandinavica. May2013, Vol. 127 Issue 5, p301-308. 8p. 1 Chart, 3 Graphs.

Subjects: Multiple sclerosis, Season of birth, Ultraviolet radiation, Medical registries, Linkage (Genetics), Cohort analysis, Epigenetics

Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice.

Authors: Lanzillo, R. Bonavita, S. Quarantelli, M. et al.

Source: Neurological Sciences. Apr2013, Vol. 34 Issue 4, p521-528. 8p.

Subjects: Natalizumab, Multiple sclerosis treatment, Immunomodulators, Immunological adjuvants, Magnetic resonance imaging of the brain

Natalizumab vs interferon beta 1a in relapsing-remitting multiple sclerosis: a head-to-head retrospective study.

Authors: Lanzillo, R. Quarantelli, M. Bonavita, S. et al.

Source: Acta Neurologica Scandinavica. Nov2012, Vol. 126 Issue 5, p306-314. 9p.

Subjects: Natalizumab, Interferons, Multiple sclerosis, Disease relapse, Immunological adjuvants, Drug efficacy, Retrospective studies

Adiponectin profile at baseline is correlated to progression and severity of multiple sclerosis.

Authors: Signoriello, E. Lus, G. Polito, R. et al.

Source: European Journal of Neurology. Feb2019, Vol. 26 Issue 2, p348-355. 8p. 1 Color Photograph, 3 Charts, 2 Graphs.

Subjects: Adiponectin, Multiple sclerosis, Autoimmune diseases, Demyelination, Adipose tissues

Ocrelizumab in a case of refractory chronic inflammatory demyelinating polyneuropathy with anti‐rituximab antibodies.

Authors: Casertano, S. Signoriello, E. Rossi, F. et al.

Source: European Journal of Neurology. Dec2020, Vol. 27 Issue 12, p2673-2675. 3p.

Subjects: Chronic inflammatory demyelinating polyradiculoneuropathy, Immunoglobulins, Antibody titer, Monoclonal antibodies, Disease relapse, Treatment effectiveness

Treatment withdrawal in relapsing−remitting multiple sclerosis: a retrospective cohort study.

Authors: Lus, G. Signoriello, E. Maniscalco, G. T. et al.

Source: European Journal of Neurology. Mar2016, Vol. 23 Issue 3, p489-493. 5p.

Subjects: Multiple sclerosis research, Demyelination, Myelin sheath diseases, Virus diseases, Neurological research

Chronic relapsing polyneuropathy associated with hepatitis B virus infection.

Authors: Lus, G. Vincitorio, CM Di Palma, A et al.

Source: Journal of the Peripheral Nervous System. Jun2004, Vol. 9 Issue 2, p115-116. 2p.

This result is not displayed to guests.
Login for full access.

Clinical and 3D instrumental assessment of the short-term effect of Sativex on patients with multiple sclerosis.

Authors: De Blasiis, P. Siani, M.F. Iolascon, G. et al.

Source: Gait & Posture. Sep2019:Supplement, Vol. 74, p12-12.

Implementing proximity care for people with multiple sclerosis in Italy: the bottom-up approach of the StayHome project.

Authors: Filippi, M. Gallo, P. Gasperini, C. et al.

Source: Journal of Neurology. Jan2025, Vol. 272 Issue 1, p1-16. 16p.

Pregnancy effect on disease activity in women with multiple sclerosis treated with cladribine.

Authors: Signoriello, E. Foschi, M. Lanzillo, R. et al.

Source: Journal of Neurology. Jul2024, Vol. 271 Issue 7, p4039-4045. 7p.

Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration.

Authors: Ferraro, D. Iaffaldano, P. Guerra, T. et al.

Source: Journal of Neurology. Mar2022, Vol. 269 Issue 3, p1463-1469. 7p.

Unusual manifestation of vertebral osteoid osteoma: case report.

Authors: Scuotto, A. Accardo, C. Rotondo, M. et al.

Source: European Radiology. Jan2002, Vol. 12 Issue 1, p109-112. 4p.

Subjects: Patients, Magnetic resonance imaging, Tomography, Medical radiography, Tumors, Histology

Migraine as possible red flag of PFO presence in suspected demyelinating disease.

Authors: Signoriello, E. Cirillo, M. Puoti, G. et al.

Source: Journal of the Neurological Sciences. Jul2018, Vol. 390, p222-226. 5p.

Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study.

Authors: Annovazzi, Pietro Capobianco, M. Moiola, L. et al.

Source: Journal of Neurology. Sep2016, Vol. 263 Issue 9, p1727-1735. 9p.

Lymphocytosis as a response biomarker of natalizumab therapeutic efficacy in multiple sclerosis.

Authors: Signoriello, E. Lanzillo, R. Brescia Morra, V. et al.

Source: Multiple Sclerosis Journal. Jun2016, Vol. 22 Issue 7, p921-925. 5p. 1 Chart, 3 Graphs.

Natalizumab in pediatric multiple sclerosis: results of a cohort of 55 cases.

Authors: Ghezzi, A Pozzilli, C Grimaldi, LME et al.

Source: Multiple Sclerosis Journal. Jul2013, Vol. 19 Issue 8, p1106-1112. 7p. 1 Diagram, 3 Charts, 1 Graph.